Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of periodontal diseases
3.2.1.2 Increasing awareness about oral health
3.2.1.3 Rising geriatric population
3.2.1.4 Technological advancements in dentistry
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited awareness and education for oral health
3.2.2.2 Stringent regulatory policies
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.6.1 Core technologies
3.6.2 Adjacent technologies
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Local antibiotic therapy
5.2.1 Minocycline hydrochloride
5.2.2 Doxycycline hyclate
5.2.3 Chlorhexidine gluconate
5.2.4 Metronidazole benzoate
5.2.5 Tetracycline hydrochloride
5.3 Systemic antibiotic therapy
5.3.1 Minocycline hydrochloride
5.3.2 Doxycycline hyclate
5.3.3 Metronidazole benzoate
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Gingivitis
6.3 Chronic periodontal disease
6.4 Aggressive periodontal disease
6.5 Necrotizing periodontal disease
6.6 Other types
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Drug stores
7.5 E-commerce
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Align Technology, Inc.
9.2 Bausch Health Companies Inc.
9.3 Cadila Healthcare Ltd.
9.4 Colgate-Palmolive Company
9.5 Danaher Corporation
9.6 Den-Mat Holdings LLC
9.7 Dentsply Sirona
9.8 Dexcel Pharma Technologies Ltd.
9.9 GlaxoSmithKline plc
9.10 Henry Schein, Inc.
9.11 Hoffmann-La Roche Ltd.
9.12 Johnson & Johnson Services, Inc.
9.13 Kaken Pharmaceutical Co., Ltd.
9.14 Pfizer Inc.
9.15 Procter & Gamble Co.
9.16 Straumann Holding AG
9.17 Sunstar Suisse SA
9.18 Teva Pharmaceutical Industries Ltd.
9.19 Zimmer Biomet Holdings, Inc.
9.20 3M Company
